Welcome to our dedicated page for Amalgamated Financial SEC filings (Ticker: AMAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Amalgamated Financial's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Amalgamated Financial's regulatory disclosures and financial reporting.
Amalgamated Financial Corp. director Bruce Maryann reported an open-market sale of Common Stock. On June 10, 2026, the director sold 2,089 shares at an average price of $41.39 per share.
After this transaction, the director directly holds 19,942 shares of Amalgamated Financial Corp. common stock, indicating that only a relatively small portion of the overall position was sold.
Amalgamated Financial Corp. executive Leslie Veluswamy, EVP & Chief Accounting Officer, completed an open-market sale of 2,500 shares of Common Stock at an average price of $43.5133 per share. Following this sale, Veluswamy directly holds 14,215 Amalgamated Financial Corp. common shares.
Amalgamated Financial Corp. expanded its share repurchase program, authorizing up to an additional $31.4 million of common stock buybacks. As of June 9, 2026, $8.6 million remained available, bringing total authorized repurchases to $40 million.
The program has no expiration date, and purchases may occur from time to time in the open market, through privately negotiated or block transactions, as determined by the CEO or CFO. The company is not obligated to repurchase any specific amount, and the Board may change or end the program at any time.
AMAL submitted a Form 144 notice relating to the proposed sale of 2,500 shares of Common Stock associated with restricted stock vesting events. The filing lists vesting dates of 02/15/2026 and 02/19/2026
The entries show three restricted stock vesting line items totaling 2,500 shares (585; 531; 1,384) tied to compensation and an intermediary listed as Morgan Stanley Smith Barney LLC. The filing names NASDAQ as the market and includes numeric references shown in the cover data.
Amalgamated Financial Corp. director Jackson Darrell B. reported an equity award on a recent Form 4. He acquired 1,623 restricted stock units on May 20, 2026, each representing a contingent right to receive one share of AMAL common stock.
The restricted stock units vest in a single installment on the first anniversary of the grant date. Following this grant, Jackson holds 11,852 shares of Amalgamated Financial Corp. common stock directly.
Lilek JoAnn S reported acquisition or exercise transactions in this Form 4 filing.
Amalgamated Financial Corp. director JoAnn S. Lilek received an equity grant of 1,623 restricted stock units on May 20, 2026, as compensation. The units vest in a single installment on the first anniversary of the grant date, with each unit delivering one share of AMAL common stock. Following this award, she holds 13,990 shares directly.
Bruce Maryann reported acquisition or exercise transactions in this Form 4 filing.
Amalgamated Financial Corp. director Bruce Maryann reported an award of 1,623 shares of common stock in the form of restricted stock units on May 20, 2026 at a reference price of $40.05 per share. These restricted stock units vest in a single installment on the first anniversary of the grant date, with each unit representing a contingent right to receive one share of AMAL stock. Following this grant, Maryann directly holds 22,031 shares of common stock.
Romney Edgar reported acquisition or exercise transactions in this Form 4 filing.
Amalgamated Financial Corp. director Edgar Romney received a grant of 1,623 restricted stock units on May 20, 2026. The award is referenced at a price of $40.05 per share and is a compensation-related grant, not an open-market purchase. The restricted stock units vest in a single installment on the first anniversary of the grant date, and each unit represents a contingent right to receive one share of AMAL common stock. Following this award, Romney’s directly held stake reported in the filing is 20,697 shares.
Amalgamated Financial Corp. director Ross Julieta reported receiving an equity grant linked to 1,623 shares of Common Stock on May 20, 2026. Footnotes explain this represents restricted stock units that vest in a single installment on the first anniversary of the grant date, with each unit delivering one AMAL share when it vests.
After the award, Ross Julieta holds a total of 5,693.94 Common Stock shares, including small amounts (9.65, 9.89 and 8.40 shares) previously acquired through a dividend reinvestment program in Q3 2025, Q4 2025 and Q1 2026. This is a compensation-related acquisition rather than an open‑market purchase.
Kelly Julie reported acquisition or exercise transactions in this Form 4 filing.
Amalgamated Financial Corp. director Kelly Julie reported receiving a grant of 1,623 restricted stock units valued at $40.05 per unit on May 20, 2026. These units vest in a single installment on the first anniversary of the grant date, each delivering one AMAL share. Following this award, Kelly Julie directly holds 20,697 shares of common stock.